Shelton Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Shelton Capital Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-19,188	Closed	-$3.52M	–	859
2021 Q2	$3.52M	Hold	19,188	–	–	0.13%	171
2021 Q1	$2.93M	Buy	19,188 +1,306	+7%	+$202K	0.1%	193
2020 Q4	$2.79M	Hold	17,882	–	–	0.13%	167
2020 Q3	$2.05M	Hold	17,882	–	–	0.09%	259
2020 Q2	$2.01M	Sell	17,882 -208	-1%	-$22.1K	0.12%	180
2020 Q1	$1.62M	Sell	18,090 -600	-3%	-$58.9K	0.14%	164
2019 Q4	$2.02M	Buy	18,690 +347	+2%	+$37.1K	0.11%	167
2019 Q3	$1.8M	Sell	18,343 -2,000	-10%	-$225K	0.11%	173
2019 Q2	$2.67M	Buy	20,343 +17,593	+640%	+$2.27M	0.16%	131
2019 Q1	$20.3K	Sell	2,750 -17,593	-86%	-$2.19M	0.08%	231
2018 Q4	$1.98M	Hold	20,343	–	–	0.14%	143
2018 Q3	$2.83M	Hold	20,343	–	–	0.16%	122
2018 Q2	$2.53M	Hold	20,343	–	–	0.16%	134
2018 Q1	$2.27M	Buy	20,343 +2,356	+13%	+$282K	0.15%	137
2017 Q4	$2.15M	Hold	17,987	–	–	0.14%	144
2017 Q3	$2.52M	Hold	17,987	–	–	0.17%	129
2017 Q2	$2.19M	Buy	17,987 +1,202	+7%	+$140K	0.15%	134
2017 Q1	$2.04M	Buy	16,785 +1,475	+10%	+$190K	0.15%	132
2016 Q4	$1.87M	Hold	15,310	–	–	0.15%	151
2016 Q3	$1.88M	Hold	15,310	–	–	0.16%	128
2016 Q2	$1.79M	Sell	15,310 -162	-1%	-$23K	0.16%	123
2016 Q1	$2.15M	Buy	15,472 +1,064	+7%	+$156K	0.2%	99
2015 Q4	$2.75M	Buy	14,408 +683	+5%	+$119K	0.27%	82
2015 Q3	$2.15M	Buy	13,725 +2,246	+20%	+$410K	0.24%	89
2015 Q2	$2.08M	Buy	11,479 +417	+4%	+$72K	0.22%	99
2015 Q1	$1.92M	Buy	11,062 +1,872	+20%	+$339K	0.21%	104
2014 Q4	$1.7M	Buy	9,190 +1,508	+20%	+$279K	0.2%	105
2014 Q3	$1.27M	Buy	7,682 +1,133	+17%	+$186K	0.17%	119
2014 Q2	$1.02M	Buy	6,549 +440	+7%	+$69.5K	0.14%	143
2014 Q1	$929K	Buy	6,109 +517	+9%	+$82.2K	0.14%	153
2013 Q4	$744K	Buy	5,592 +726	+15%	+$87.1K	0.11%	188
2013 Q3	$565K	Buy	4,866 +156	+3%	+$17.1K	0.09%	242
2013 Q2	$434K	Buy	+4,710	New	+$454K	0.08%	312

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return